Related references
Note: Only part of the references are listed.Cell-derived extracellular matrix enhanced by collagen-binding domain-decorated exosomes to promote neural stem cells neurogenesis
Yuanxin Zhai et al.
BIOMEDICAL MATERIALS (2022)
Targeting type I collagen for cancer treatment
Run Shi et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer
Jiayang Liu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer
Yang Chen et al.
CANCER CELL (2022)
Fibronectin in development and wound healing
Jennifer Patten et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
Xiujie Sun et al.
NATURE (2021)
Collagen Binding Proteins of Gram-Positive Pathogens
Srishtee Arora et al.
FRONTIERS IN MICROBIOLOGY (2021)
Lumican in Carcinogenesis-Revisited
Eirini-Maria Giatagana et al.
BIOMOLECULES (2021)
Emerging roles of ECM remodeling processes in cancer
Vishnu Mohan et al.
SEMINARS IN CANCER BIOLOGY (2020)
Collagen-binding IL-12 inflames 'cold' tumours
Juergen Scheller et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
Aslan Mansurov et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Targeted antibody and cytokine cancer immunotherapies through collagen affinity
Jun Ishihara et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
Noor Momin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Adverse events associated with immune checkpoint inhibitor treatment for cancer
Khashayar Esfahani et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2019)
The Collagen Suprafamily: From Biosynthesis to Advanced Biomaterial Development
Anna Sorushanova et al.
ADVANCED MATERIALS (2019)
Novel protein therapeutic joint retention strategy based on collagen-binding Avimers
Joanne T. Hulme et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2018)
Lumican as a multivalent effector in wound healing
Konstantina Karamanou et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft
Anni Pan et al.
DRUG DELIVERY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Basic Fibroblast Growth Factor Fused with Tandem Collagen-Binding Domains from Clostridium histolyticum Collagenase ColG Increases Bone Formation
Hiroyuki Sekiguchi et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Collagen-binding proteins of Streptococcus mutans and related streptococci
A. Aviles-Reyes et al.
MOLECULAR ORAL MICROBIOLOGY (2017)
Placental growth factor and pre-eclampsia
K. Chau et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome
Dominic Cosgrove et al.
MATRIX BIOLOGY (2017)
Design and Use of Chimeric Proteins Containing a Collagen-Binding Domain for Wound Healing and Bone Regeneration
Cyril Addi et al.
TISSUE ENGINEERING PART B-REVIEWS (2017)
Reorganized Collagen in the Tumor Microenvironment of Gastric Cancer and Its Association with Prognosis
Zhi-Hua Zhou et al.
JOURNAL OF CANCER (2017)
Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer
Maria E. Suarez-Almazor et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Advances in the design and higher-order assembly of collagen mimetic peptides for regenerative medicine
Kevin Strauss et al.
CURRENT OPINION IN BIOTECHNOLOGY (2017)
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
Caroline Happold et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
vwF A3-GPI modification of EPCs accelerates reendothelialization of injured vessels via collagen targeting in mice
Hu Tan et al.
JOURNAL OF DRUG TARGETING (2016)
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul T. Nghiem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A collagen-binding EGFR antibody fragment targeting tumors with a collagen-rich extracellular matrix
Hui Liang et al.
SCIENTIFIC REPORTS (2016)
Crucial role for the VWF A1 domain in binding to type IV collagen
Veronica H. Flood et al.
BLOOD (2015)
von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends
Peter J. Lenting et al.
BLOOD (2015)
A collagen-binding EGFR single-chain Fv antibody fragment for the targeted cancer therapy
Hui Liang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Analysis of Lagrange Interpolation for Functions with a Boundary Layer Component
Alexander Zadorin
Finite Difference Methods, Theory and Applications (2015)
Collagen-Based Biomaterials for Wound Healing
Sayani Chattopadhyay et al.
BIOPOLYMERS (2014)
A von Willebrand factor fragment containing the D′D3 domains is sufficient to stabilize coagulation factor VIII in mice
Andrew Yee et al.
BLOOD (2014)
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
Mara H. Sherman et al.
CELL (2014)
Definition of the Native and Denatured Type II Collagen Binding Site for Fibronectin Using a Recombinant Collagen System*
Bo An et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing
Mikael M. Martino et al.
SCIENCE (2014)
The collagen scaffold with collagen binding BDNF enhances functional recovery by facilitating peripheral nerve infiltrating and ingrowth in canine complete spinal cord transection
S. Han et al.
SPINAL CORD (2014)
Role of Collagen Matrix in Tumor Angiogenesis and Glioblastoma Multiforme Progression
Tadanori Mammoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
WNT1 mutation with recessive osteogenesis imperfecta and profound neurological phenotype
Eissa Faqeih et al.
JOURNAL OF MEDICAL GENETICS (2013)
Critical von Willebrand factor A1 domain residues influence type VI collagen binding
V. H. Flood et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Extracellular Matrix Proteins in Hemostasis and Thrombosis
Wolfgang Bergmeier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
PlGF: A Multitasking Cytokine with Disease-Restricted Activity
Mieke Dewerchin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
Sid P. Kerkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Collagen mimetic peptides: progress towards functional applications
S. Michael Yu et al.
SOFT MATTER (2011)
The Collagen Family
Sylvie Ricard-Blum
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
The promotion of neurological recovery in the rat spinal cord crushed injury model by collagen-binding BDNF
Weibang Liang et al.
BIOMATERIALS (2010)
Property of Nano-thickness Nickel Silicides with Low Temperature Catalytic CVD
Yongyoon Choi et al.
KOREAN JOURNAL OF METALS AND MATERIALS (2010)
Why are tumour blood vessels abnormal and why is it important to know?
J. A. Nagy et al.
BRITISH JOURNAL OF CANCER (2009)
Linear Ordered Collagen Scaffolds Loaded with Collagen-Binding Brain-Derived Neurotrophic Factor Improve the Recovery of Spinal Cord Injury in Rats
Qianqian Han et al.
TISSUE ENGINEERING PART A (2009)
Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment
Yu Liang et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2
Bing Chen et al.
BIOMATERIALS (2007)
The effect of collagen-targeting platelet-derived growth factor on cellularization and vascularization of collagen scaffolds
Hang Lin et al.
BIOMATERIALS (2006)
Establishment of a functionally active collagen-binding vascular endothelial growth factor fusion protein in situ
Tetsuya Ishikawa et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Collagen binding by the mannose receptor mediated through the fibronectin type 11 domain
CE Napper et al.
BIOCHEMICAL JOURNAL (2006)
All six modules of the gelatin-binding domain of fibronectin are required for full affinity
Y Katagiri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Human fibronectin and MMP-2 collagen binding domains compete for collagen binding sites and modify cellular activation of MMP-2
B Steffensen et al.
MATRIX BIOLOGY (2002)
Collagens and collagen-related diseases
J Myllyharju et al.
ANNALS OF MEDICINE (2001)
Tumor angiogenesis
M Detmar
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2000)